A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction (clinicaltrials.gov) - May 12, 2026 - P2 | N=48 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting | Initiation date: Dec 2025 ➔ Mar 2026
Enrollment open • Trial initiation date • Cardiovascular • Congestive Heart Failure • Heart Failure
|